About me

Head of the Pulmonary Medicine and Respiratory Allergy Departmen at the Hospital Clinic de Barcelona. Currently, Head of the Pulmonary Hypertension Unit of the Hospital Clínic, National Reference Unit for Complex Pulmonary Hypertension, belonging to the European Reference Network for Rare Lung Diseases (ERN-LUNG). Research interests focus on pulmonary vascular diseases, especially those associated with chronic respiratory diseases; the pathogenesis of pulmonary hypertension associated with chronic obstructive pulmonary disease, both at the cellular and molecular level; and the physiology of vascular regulation of gas exchange.

Featured publications

  • ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension

    Authors: Grünig E, Eichstaedt C, Barberà JA, Benjamin N, Blanco I, Bossone E, Cittadini A, Coghlan G, Corris P, D'Alto M, D'Andrea A, Delcroix M, de Man F, Gaine S, Ghio S, Gibbs S, Gumbiene L, Howard LS, Johnson M, Jurevi?ien? E, Kiely DG, Kovacs G, MacKenzie A, Marra AM, McCaffrey N, McCaughey P, Naeije R, Olschewski H, Pepke-Zaba J, Reis A, Santos M, Saxer S, Tulloh RM, Ulrich S, Vonk Noordegraaf A, Peacock AJ .
    Reference: EUROPEAN RESPIRATORY JOURNAL 2019; 53(2):-.
  • The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension

    Authors: Newnham M; South K; Bleda M; Auger WR; Barberà JA; Bogaard H; Bunclark K; Cannon JE; Delcroix M; Hadinnapola C; Howard LS; Jenkins D; Mayer E; Ng C; Rhodes CJ; Screaton N; Sheares K; Simpson MA; Southwood M; Su L; Taboada D; Traylor M; Trembath RC; Villar SS; Wilkins MR; Wharton J; Gräf S; Pepke-Zaba J; Laffan M; Lane DA; Morrell NW; Toshner M .
    Reference: EUROPEAN RESPIRATORY JOURNAL 2019.
  • Pulmonary Vascular Density: Comparison of Findings on CT Imaging with Histology

    Authors: Rahaghi FN, Argemí G, Nardelli P, Domínguez-Fandos D, Arguis P, Peinado VI, Ross JC, Ash SY, de La Bruere I, Come CE, Diaz AA, Sánchez M, Washko GR, Barberà JA, San José Estépar R .
    Reference: EUROPEAN RESPIRATORY JOURNAL 2019.
  • Pulmonary hypertension in chronic lung disease and hypoxia

    Authors: Nathan SD; Barbera JA; Gaine SP; Harari S; Martinez FJ; Olschewski H; Olsson KM; Peacock AJ; Pepke-Zaba J; Provencher S; Weissmann N; Seeger W.
    Reference: 2019.
  • Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: Highlights from basic research to therapy.

    Authors: Huertas A; Guignabert C; Barberà JA; Bärtsch P; Bhattacharya J; Bhattacharya S; Bonsignore MR; Dewachter L; Dinh-Xuan AT; Dorfmüller P; Gladwin MT; Humbert M; Kotsimbos T; Vassilakopoulos T; Sanchez O; Savale L; Testa U; Wilkins MR.
    Reference: EUROPEAN RESPIRATORY JOURNAL 2018.
  • Pulmonary Vascular Involvement in COPD - Is There a Pulmonary Vascular Phenotype?

    Authors: Kovacs G, Agusti A, Barberà JA, Celli B, Criner G, Humbert M, Sin DD, Voelkel N, Olschewski H .
    Reference: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2018.
  • Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): Subgroup analysis from the AMBITION trial

    Authors: Coghlan JG; Galiè N; Barberà JA; Frost AE; Ghofrani HA; Hoeper MM; Kuwana M; McLaughlin VV; Peacock AJ; Simonneau G; Vachiéry JL; Blair C; Gillies H; Miller KL; Harris JHN; Langley J; Rubin LJ.
    Reference: ANNALS OF THE RHEUMATIC DISEASES 2017.
  • An official European Respiratory Society statement: pulmonary haemodynamics during exercise.

    Authors: Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, Garcia G, Grünig E, Howard L, Humbert M, Lau E, Laveneziana P, Lewis GD, Naeije R, Peacock A, Rosenkranz S, Saggar R, Ulrich S, Vizza D, Vonk Noordegraaf A, Olschewski H .
    Reference: EUROPEAN RESPIRATORY JOURNAL 2017.
  • Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study

    Authors: Hoeper; Marius M McLaughlin; Vallerie V Albert Barbera; Joan Frost; Adaani E Ghofrani; Hossein-Ardeschir Peacock; Andrew J Simonneau; Gerald Rosenkranz; Stephan Oudiz; Ronald J White; R James Miller; Karen L Langley; Jonathan Harris; Julia H N Blair; Christiana Rubin; Lewis J Vachiery; Jean-Luc.
    Reference: THE LANCET. RESPIRATORY MEDICINE 2016.
  • Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry

    Authors: Delcroix M; Lang I; Pepke-Zaba J; Jansa P; D'Armini AM; Snijder R; Bresser P; Torbicki A; Mellemkjaer S; Lewczuk J; Simkova I; Barberà JA; de Perrot M; Hoeper MM; Gaine S; Speich R; Gomez-Sanchez MA; Kovacs G; Jaïs X; Ambroz D; Treacy C; Morsolini M; Jenkins D; Lindner J; Dartevelle P; Mayer E; Simonneau G .
    Reference: CIRCULATION 2016.

Featured Projects

  • Caracterización fenotípica de la hipertensión pulmonar en las enfermedades respiratorias

    Funder: INSTITUTO DE SALUD CARLOS III
    Duration: 01/01/2019 - 31/12/2021
  • Proliferación celular en la hipertensión pulmonar: Detección y mecanismos de regulación epigenética

    Funder: INSTITUTO DE SALUD CARLOS III
    Duration: 01/01/2016 - 31/12/2018
  • Recerca traslacional en malalties pulmonars

    Principal investigator: Joan Albert Barberà
    Funder: AGÈNCIA DE GESTIÓ D’AJUTS UNIVERSITARIS I DE RECERCA
    Duration: 01/03/2018 - 28/02/2021
  • Targeting endothelial dysfunction in highly prevalent diseases: characterization and validation of prognostic biomarkers and identification of potential therapeutic strategies

    Principal investigator: Joan Albert Barberà
    Funder: INSTITUTO DE SALUD CARLOS III
    Duration: 01/01/2016 - 31/12/2018
  • MoGlyNet. Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study

    Principal investigator: Joan Albert Barberà
    Funder: UNIÓN EUROPEA
    Duration: 15/09/2015 - 31/12/2019